After kickstarting the GLP-1 wave that transformed the pharma landscape and briefly sending its market value above Denmark’s annual economic output, Novo Nordisk now trades about 5% below where its shares stood five years ago. After its shares hit an all-time closing high of $137.40 on June 25, 2024, the stock slid about 66% to…
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says
Amazon Web Services today launched Amazon Bio Discovery, an application that routes AI-designed antibody candidates directly to DNA Synthesis firm Twist Bioscience and the techbio Ginkgo Bioworks for synthesis and testing, with results flowing back into the same interface that generated them. AWS launched Amazon Bio Discovery with Bayer, the Broad Institute, Memorial Sloan Kettering…
Eversana’s AWS alliance aims to cut red tape in pharma regulatory paperwork
In July, the life sciences services company Eversana revealed it was partnering with AWS to tap generative AI (gen AI) for pharma and other life science customers. It aimed to “pharmatize” gen AI, as the company put it then. Now, the company has revealed the first technology from that partnership – a regulatory review automation…